Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaojidaozhi decoction is a traditional Chinese herbal medicine formula first documented in the 13th-century medical text *Pi Wei Lun* (Treatise on the Spleen and Stomach) by Li Dongyuan. It is composed of twelve herbs and is traditionally used to treat childhood functional constipation by improving gastric and splenic function, eliminating food stagnation, and clearing pathological heat accumulation. The decoction is thought to increase intestinal fluid and facilitate gastrointestinal motility. It has been evaluated in clinical trials, such as those sponsored by Shengjing Hospital of China Medical University, to assess its efficacy and safety compared to standard treatments like polyethylene glycol (PEG) 3350.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaojidaozhi decoction.